pentoxifylline has been researched along with Cardiomyopathy, Chagas in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Silva Grijó Farani, P | 1 |
| Iandra da Silva Ferreira, B | 1 |
| Begum, K | 1 |
| Vilar-Pereira, G | 2 |
| Pereira, IR | 2 |
| Fernández-Figueroa, EA | 1 |
| Cardenas-Ovando, RA | 1 |
| Almeida, IC | 1 |
| Roy, S | 1 |
| Lannes-Vieira, J | 2 |
| Moreira, OC | 2 |
| Ramos, IP | 1 |
| Gibaldi, D | 1 |
| Britto, C | 1 |
| Moraes, MO | 1 |
2 other studies available for pentoxifylline and Cardiomyopathy, Chagas
| Article | Year |
|---|---|
Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy.
Topics: Animals; Chagas Cardiomyopathy; Chagas Disease; Disease Models, Animal; Fibrosis; Gene Expression Pr | 2023 |
Pentoxifylline reverses chronic experimental Chagasic cardiomyopathy in association with repositioning of abnormal CD8+ T-cell response.
Topics: Animals; CD8-Positive T-Lymphocytes; Chagas Cardiomyopathy; Connexin 43; Heart; Interferon-gamma; Mi | 2015 |